Insights

How much money is in the bank today? For many companies, that’s an important question. However, for a life sciences company, it’s rarely the right one. What matters more is how much time is available to reach the next scientific or commercial milestone.

For many life sciences companies, financing is not a one-off event but a recurring part of their growth strategy. New investments are needed to reach the next development phase, and at the same time, that very progress determines investor confidence.